Shandong Xinhua Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This Disclosure score covers seventeen UN SDGs including: 'No Poverty', 'Industry, Innovation & Infrastructure' and 'Life on Land'. If you work at Shandong Xinhua Pharmaceutical Co Ltd and you wish to licence your Sustainability rating, please get in touch. Full Sustainability assessment of Shandong Xinhua Pharmaceutical Co Ltd can be accessed by logging in.
Shandong Xinhua Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.4.
7.5
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
149 | Virbac SA | 7.6 | High |
160 | Shandong Xinhua Pharmaceutical Co Ltd | 7.5 | High |
160 | C4X Discovery Holdings PLC | 7.5 | High |
160 | Ascentage Pharma Group International | 7.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Shandong Xinhua Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Shandong Xinhua Pharmaceutical Co Ltd report the average age of the workforce?
Does Shandong Xinhua Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Shandong Xinhua Pharmaceutical Co Ltd offer flexible work?
Does Shandong Xinhua Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Shandong Xinhua Pharmaceutical Co Ltd conduct supply chain audits?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Shandong Xinhua Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose water use targets?
Does Shandong Xinhua Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Shandong Xinhua Pharmaceutical Co Ltd have a product recall in the last two years?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Shandong Xinhua Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Shandong Xinhua Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose parental leave metrics?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Shandong Xinhua Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Shandong Xinhua Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Shandong Xinhua Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose its waste policy?
Does Shandong Xinhua Pharmaceutical Co Ltd report according to TCFD requirements?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose energy use targets?
Does Shandong Xinhua Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Shandong Xinhua Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Shandong Xinhua Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.